Free Trial

QT Imaging (QTI) Competitors

QT Imaging logo
$0.56 +0.01 (+1.82%)
As of 04/4/2025

QTI vs. VANI, GUTS, INO, HYPR, CTSO, APT, ICAD, MBOT, TELA, and APYX

Should you be buying QT Imaging stock or one of its competitors? The main competitors of QT Imaging include Vivani Medical (VANI), Fractyl Health (GUTS), Inovio Pharmaceuticals (INO), Hyperfine (HYPR), Cytosorbents (CTSO), Alpha Pro Tech (APT), iCAD (ICAD), Microbot Medical (MBOT), TELA Bio (TELA), and Apyx Medical (APYX). These companies are all part of the "medical equipment" industry.

QT Imaging vs.

QT Imaging (NASDAQ:QTI) and Vivani Medical (NASDAQ:VANI) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, media sentiment, valuation, risk, community ranking and dividends.

Vivani Medical has a consensus target price of $4.00, suggesting a potential upside of 316.67%. Given Vivani Medical's stronger consensus rating and higher possible upside, analysts plainly believe Vivani Medical is more favorable than QT Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
QT Imaging
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Vivani Medical
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

24.2% of QT Imaging shares are held by institutional investors. Comparatively, 6.8% of Vivani Medical shares are held by institutional investors. 75.4% of QT Imaging shares are held by insiders. Comparatively, 44.3% of Vivani Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

QT Imaging has higher revenue and earnings than Vivani Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
QT Imaging$4.00M3.80-$4.03MN/AN/A
Vivani MedicalN/AN/A-$25.65M-$0.45-2.13

QT Imaging has a beta of -0.2, indicating that its stock price is 120% less volatile than the S&P 500. Comparatively, Vivani Medical has a beta of 3.2, indicating that its stock price is 220% more volatile than the S&P 500.

In the previous week, Vivani Medical had 6 more articles in the media than QT Imaging. MarketBeat recorded 8 mentions for Vivani Medical and 2 mentions for QT Imaging. QT Imaging's average media sentiment score of 0.00 beat Vivani Medical's score of -0.24 indicating that QT Imaging is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
QT Imaging
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Vivani Medical
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

Vivani Medical received 5 more outperform votes than QT Imaging when rated by MarketBeat users.

CompanyUnderperformOutperform
QT ImagingN/AN/A
Vivani MedicalOutperform Votes
5
100.00%
Underperform Votes
No Votes

QT Imaging's return on equity of 0.00% beat Vivani Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
QT ImagingN/A N/A -65.94%
Vivani Medical N/A -102.42%-49.21%

Summary

Vivani Medical beats QT Imaging on 7 of the 13 factors compared between the two stocks.

Remove Ads
Get QT Imaging News Delivered to You Automatically

Sign up to receive the latest news and ratings for QTI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

QTI vs. The Competition

MetricQT ImagingElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$15.20M$3.06B$5.25B$7.12B
Dividend YieldN/A1.64%4.89%4.06%
P/E RatioN/A14.0021.2317.48
Price / Sales3.8042.73354.9985.32
Price / CashN/A44.0938.1834.64
Price / Book-0.293.146.243.79
Net Income-$4.03M$94.03M$3.20B$247.48M
7 Day Performance6.67%-6.46%-8.39%-6.69%
1 Month Performance46.39%-15.48%-4.82%-11.43%
1 Year Performance-46.15%-27.14%2.54%-7.73%

QT Imaging Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QTI
QT Imaging
N/A$0.56
+1.8%
N/A-42.8%$15.20M$4.00M0.00N/A
VANI
Vivani Medical
2.5491 of 5 stars
$1.03
-2.4%
$4.00
+290.2%
-52.0%$60.72MN/A-2.2820Earnings Report
Analyst Forecast
GUTS
Fractyl Health
1.3023 of 5 stars
$1.20
+1.2%
$10.00
+730.6%
-85.0%$58.51M$93,000.00-0.10102Upcoming Earnings
Gap Down
INO
Inovio Pharmaceuticals
3.6305 of 5 stars
$1.58
-3.4%
$12.20
+674.6%
-86.9%$57.75M$217,756.00-0.39320
HYPR
Hyperfine
2.9894 of 5 stars
$0.74
+3.2%
$1.33
+80.0%
-30.5%$56.97M$12.89M-1.28190Gap Down
CTSO
Cytosorbents
1.9057 of 5 stars
$1.01
+0.5%
$4.67
+364.3%
+1.6%$54.95M$33.79M-2.79220Earnings Report
Analyst Forecast
Analyst Revision
News Coverage
APT
Alpha Pro Tech
N/A$5.01
+0.2%
N/A-33.1%$54.47M$57.84M13.54120Analyst Forecast
News Coverage
ICAD
iCAD
0.2083 of 5 stars
$2.05
-0.7%
N/A+7.4%$54.14M$19.61M-15.69140Gap Down
MBOT
Microbot Medical
1.6457 of 5 stars
$1.51
-0.3%
$9.00
+498.0%
+18.3%$52.29MN/A-1.8820News Coverage
TELA
TELA Bio
2.336 of 5 stars
$1.23
+0.8%
$7.25
+489.4%
-79.5%$48.45M$69.30M-0.73120
APYX
Apyx Medical
1.7217 of 5 stars
$1.30
-4.8%
N/A-35.3%$47.81M$48.10M-1.52270Gap Down
Remove Ads

Related Companies and Tools


This page (NASDAQ:QTI) was last updated on 4/5/2025 by MarketBeat.com Staff
From Our Partners